restructuring
Invitae Posts 9 Percent Q3 Revenue Decline
The firm also reported a $942.1 million net loss driven by a restructuring undertaken in 2022.
GeneDx Lays off 10 Percent of Staff as Part of $40M Cost Cutting Plan, Secures $75M Debt Financing
The clinical genetic testing company also lowered its revenue guidance for 2023 and reported $53.3 million in revenues for the third quarter.
Biocartis Restructures Balance Sheet as H1 2023 Revenues Rise 12 Percent
The company said that its secured creditors have recapitalized its operating subsidiaries and restructured its balance sheet to reduce its debt burden by €132 million.
DermTech to Cut 15 Percent of Workforce in Restructuring to Focus on Skin Cancer Test
The San Diego-based company said it will halt its pipeline programs in order to focus on growing volume and reimbursement for its noninvasive melanoma DNA test.
Akoya Biosciences Reduces Workforce; Plans to Raise $44M in Public Offering
The company has completed a moderate restructuring across all levels and departments as part of its effort to drive efficiency but declined to provide further details, such as the number of staff terminated.